Pharmaceutical Industries Ltd.
Your browser does not support iframes.
See Teva's sites around the world
Bosnia & Herzegovina
Want to find out more about Teva's locations and phone numbers?
Visit Teva Worldwide
2017 Annual Report – Form 10-K
Over the Counter (OTC)
Central Nervous System (CNS)
Teva Specialty Pipeline
Positions & Policies
Social Impact Report
Multiple Chronic Conditions
Events & Presentations
Dare to be different
Our Guiding Values
Working at Teva
Dare to be different
Search Teva Jobs
Go to Parent
In our generics R&D, there is much more to generics than meets the eye. We bring creativity, innovative thinking, and the ability to analyze, formulate and execute in a timely and effective manner. This is particularly true in the area of complex, hard to develop generics, where we deliver a real competitive edge.
Share on Facebook
Share on LinkedIn
Share on Twitter
Generics. More than Meets the Eye
Our generics R&D is closely integrated with our extensive clinical expertise in developing specialty and OTC products. This makes us the only global pharmaceutical company that has an integrated generic and specialty (branded) R&D capability.
With generics R&D and specialty R&D working hand-in-hand, this unique combination of strengths, capabilities and skills enables new ideas and improved innovation.
Proud of Our Heritage, Inspired by New Possibilities
Great medicines start with great minds. Our R&D group maintains a mindset of exceptional professionalism, matched by speed, flexibility and a desire for value creation for patients, healthcare providers and customers worldwide. Our strengths in generics R&D are directed at fostering discovery and innovation.
Our generics R&D capabilities have expanded beyond tablets, capsules, liquids, ointments and creams to a broad range of dosage forms and delivery systems. These include sterile devices, modified release parenteral injectables, transdermal patches and films, and nasal suspensions. Our generics R&D group continues to develop an array of special delivery technologies ranging from extended-release to drug device combinations.
More Value for More People Around the World
We’re working around the world, and around the clock to deliver affordable medicines in a multitude of therapeutic areas. Our generics R&D activities are carried out in development centers in the United States, Europe, Latin America, Israel, Japan and India. We are focused on the development of complex, difficult to produce, high-value treatment options to address the unmet needs of patients and improve health outcomes.